Niraj James Shah

429 total citations
59 papers, 325 citations indexed

About

Niraj James Shah is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Niraj James Shah has authored 59 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Epidemiology, 28 papers in Hepatology and 12 papers in Surgery. Recurrent topics in Niraj James Shah's work include Liver Disease Diagnosis and Treatment (23 papers), Hepatitis C virus research (15 papers) and Liver Disease and Transplantation (13 papers). Niraj James Shah is often cited by papers focused on Liver Disease Diagnosis and Treatment (23 papers), Hepatitis C virus research (15 papers) and Liver Disease and Transplantation (13 papers). Niraj James Shah collaborates with scholars based in United States, India and United Kingdom. Niraj James Shah's co-authors include Patrick Basu, Mark M. Aloysius, Tommy Pacana, Robert S. Brown, Amreen Dinani, Robert S. Brown, Nimy John, Hemant Goyal, Kumar Pallav and R. Dale Brown and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Gut.

In The Last Decade

Niraj James Shah

53 papers receiving 315 citations

Peers

Niraj James Shah

EPIDE

SURGE

HEPAT

GASTR

Patrick Basu United States

Mohammad Reza Ghadir Iran

Amr Shaaban Hanafy Egypt

Tajana Filipec Kanižaj Croatia

Claudio Rodríguez-Ramos Spain

Takuji Fujisawa Japan

Charles Onyekwere Nigeria

Samah Soliman Egypt

Mohd Talha Noor India

Michael K. K. Li China

Patrick Basu United States

Niraj James Shah

157 ×1.1

EPIDE

141 ×1.1

SURGE

97 ×1.1

HEPAT

58 ×1.0

62 ×1.1

GASTR

Citations per year, relative to Niraj James Shah Niraj James Shah (= 1×) peers Patrick Basu

Countries citing papers authored by Niraj James Shah

Since Specialization

Citations

This map shows the geographic impact of Niraj James Shah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niraj James Shah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niraj James Shah more than expected).

Fields of papers citing papers by Niraj James Shah

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Niraj James Shah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niraj James Shah. The network helps show where Niraj James Shah may publish in the future.

Co-authorship network of co-authors of Niraj James Shah

This figure shows the co-authorship network connecting the top 25 collaborators of Niraj James Shah. A scholar is included among the top collaborators of Niraj James Shah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Niraj James Shah. Niraj James Shah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Aloysius, Mark M., et al.. (2024). National Trends in the Incidence of Sporadic Malignant Colorectal Polyps in Young Patients (20–49 Years): An 18-Year SEER Database Analysis. Medicina. 60(4). 673–673. 2 indexed citations

Aloysius, Mark M., et al.. (2023). Fibrolamellar hepatocellular carcinoma: An epidemiologic and 5-year cancer survival assessment based off SEER data. Clinics and Research in Hepatology and Gastroenterology. 47(7). 102162–102162.

Aloysius, Mark M., et al.. (2023). Cancer-specific survival in non-mucinous appendiceal adenocarcinomas after local resection versus right hemicolectomy: A Surveillance, Epidemiology, and End Results database study. Surgery. 174(4). 759–765. 2 indexed citations

Shah, Niraj James, et al.. (2023). Hip-Spine Discordance in Bone Mineral Densities in Patients Undergoing Dual Energy X-Ray Absorptiometry Scan in a Tertiary Care Centre: A Descriptive Cross-sectional Study. SHILAP Revista de lepidopterología. 61(262). 502–505.

Shah, Niraj James, et al.. (2022). Epidemiology and outcomes of gastrointestinal mucosal melanomas: a national database analysis. BMC Gastroenterology. 22(1). 178–178. 4 indexed citations

Sheikh, Abdul Ahad Ehsan, et al.. (2021). Spontaneous Pneumobilia: Not So Benign. Cureus. 13(4). e14486–e14486. 2 indexed citations

Shah, Niraj James, Mark M. Aloysius, Neil Sharma, & Kumar Pallav. (2021). Advances in treatment and prevention of hepatitis B. World Journal of Gastrointestinal Pharmacology and Therapeutics. 12(4). 56–78. 3 indexed citations

Shah, Niraj James & Savio John. (2019). Acute and Chronic Liver Failure. StatPearls. 1 indexed citations

Shah, Niraj James & Mark W. Russo. (2017). Is it time to rethink combined liver-kidney transplant in hepatitis C patients with advanced fibrosis?. World Journal of Hepatology. 9(5). 288–288. 1 indexed citations

10.

Basu, Patrick, et al.. (2016). Sofosbuvir, ledipasvir in IBD treated patients with advanced biologics including ribavirin eradicating chronic hepatitis C: SOLATAIRE C Trial. A multi-center clinical prospective pilot study. HPB. 18. e299–e299. 1 indexed citations

11.

Basu, Patrick, et al.. (2014). The effect of melatonin in functional heartburn: A randomized, placebo-controlled clinical trial. Open Journal of Gastroenterology. 4(2). 56–61. 10 indexed citations

12.

Basu, Patrick, et al.. (2013). Prevalence of Small Bowel Bacterial Overgrowth (SIBO) in Decompensated Cirrhosis with Portal Hypertension: A Clinical Pilot Study. The American Journal of Gastroenterology. 108. S144–S145. 1 indexed citations

13.

Basu, Patrick, et al.. (2013). Curcumin, anti-oxidant, and pioglitazone therapy with inclusion of vitamin e in non-alcoholic fatty liver disease-a randomized open label placebo controlled clinical prospective trial (captive). Journal of Clinical and Experimental Hepatology. 3(1). S26–S27. 4 indexed citations

14.

Basu, Patrick, et al.. (2013). Su1697 Restless Leg Syndrome (RLS) Is Associated With Hepatic Encephalopathy (HE) in Decompensated Cirrhosis. a Clinical Pilot Study. Gastroenterology. 144(5). S–1000. 2 indexed citations

15.

Basu, Patrick, et al.. (2011). A Randomized Study Comparing Levofloxacin, Omeprazole, Nitazoxanide, and Doxycycline versus Triple Therapy for the Eradication of Helicobacter pylori. The American Journal of Gastroenterology. 106(11). 1970–1975. 82 indexed citations

16.

Basu, Patrick, et al.. (2010). S1272 Effect of High-Dose Ribavirin (RBV), Alinia (Nitazoxanide) and Pegylated Interferon (pegIFN) Alfa-2a in Attaining Sustained Virologic Response (SVR) in Treatment of Chronic Hepatitis C (ERAIS-C Trial) in Naïve Genotype 1 Patients. Gastroenterology. 138(5). S–218. 1 indexed citations

17.

Basu, Patrick, et al.. (2010). Effect of Melatonin in Functional Heart Burn-A Randomized Placebo-Controlled Clinical Trial. The American Journal of Gastroenterology. 105. S497–S497.

18.

Shah, Niraj James, et al.. (2010). OL-010 Sequential use of nitazoxanide (NTZ) as a salvage therapy in patient with recurrent mild to moderate Clostridium difficile infection (CDI): a prospective, open-label, randomized clinical trial. International Journal of Infectious Diseases. 14. S5–S5. 1 indexed citations

19.

Basu, Patrick, et al.. (2010). Sequential Use of Nitazoxanide (NTZ) as a Salvage Therapy in Patient with Recurrent Mild to Moderate Clostridium Difficile Infection (CDI): A Prospective, Open-label, Randomized Clinical Trial. The American Journal of Gastroenterology. 105. S142–S142. 1 indexed citations

20.

Shah, Niraj James, et al.. (1970). Some reflections on emetine and the heart.. Journal of the Association of Physicians of India. 18(11). 897–905. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact